A Prospective Feasibility Study Using CtDNA to Tailor Neoadjuvant Chemotherapy for Patients with Colorectal or Appendiceal Adenocarcinoma
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT05947838
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT05933252
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05928325
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphoma
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05929716
A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT05929612
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT05922904
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 51
- Registration Number
- NCT05922930
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Harmony & Health: A Culturally Adapted Mindbody Intervention to Reduce Sitting Time and Improve Psychosocial Wellbeing in Black Adults
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT05922943
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients with Advanced Cancer
Not yet recruiting
- Conditions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT05904782
An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients
Suspended
- Conditions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05904899
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath